Supernus Pharmaceuticals Inc
F:S49
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Supernus Pharmaceuticals Inc
F:S49
|
US |
|
E
|
EA Technique (M) Bhd
KLSE:EATECH
|
MY |
|
Opendoor Technologies Inc
NASDAQ:OPEN
|
US |
|
C
|
Clearsign Technologies Corp
F:4CC
|
US |
Wall St Price Targets
S49 Price Targets Summary
Supernus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for S49 is 64.16 EUR with a low forecast of 55.61 EUR and a high forecast of 69.38 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S49's stock price target?
Price Target
64.16
EUR
According to Wall Street analysts, the average 1-year price target for S49 is 64.16 EUR with a low forecast of 55.61 EUR and a high forecast of 69.38 EUR.
What is the Revenue forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 3 years is 18%.
What is the Gross Profit forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 59%. The projected CAGR for the next 3 years is 16%.
What is the Operating Income forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
205%
The compound annual growth rate for Operating Income over the next 3 years is 205%.
